| AGIOS PHARMACEUT. DL-,001 |
| USA |
| Gesundheit |
| US00847X1046 / A1W2RM |
| 8AP (Frankfurt) / AGIO (NASDAQ) |
| FRA:8AP, ETR:8AP, 8AP:GR, NASDAQ:AGIO |
| - |
| https://www.agios.com/ |
|
Agios Pharmaceuticals Inc. is a biopharmaceutical company specializing in cellular metabolism to develop differentiated medicines for rare diseases, with a particular emphasis on classical hematology. The company focuses on creating potentially trans..
>Volltext.. |
| 1500.06 Mio. EUR |
| 812.98 Mio. EUR |
| 46.71 Mio. EUR |
| -403.74 Mio. EUR |
| -356.9 Mio. EUR |
| -6.16 EUR |
| 34.76 Mio. EUR |
| 77.06 Mio. EUR |
| -322.49 Mio. EUR |
| 10.39 |
| 30.47% |
| -154% |
| - |
| - |
| - |
| AGIOS |
| 02.04.26 |
|